Impaired colony-forming capacity of circulating endothelial progenitor cells in patients with emphysema.

Tohoku J Exp Med

Department of Internal Medicine, CHA Bundang Medical Center, College of Medicine, CHA University, Seongnam, Korea.

Published: August 2012

Chronic obstructive pulmonary disease (COPD) is classified into emphysema and chronic bronchitis, which are thought to result from different pathophysiological pathways. Smoking-induced lung parenchymal destruction and inadequate repair are involved in the pathogenesis of emphysema. In addition, decreased expression of vascular endothelial growth factor and increased endothelial cell apoptosis in the lung may participate in emphysema pathogenesis. As stem cells, circulating endothelial progenitor cells (EPCs) may play a key role in the maintenance of vascular integrity by replacing and repairing the damaged endothelial cells in the tissues. To determine whether the lack of appropriate repair by circulating EPCs in cases of smoking-induced endothelial cell injury participates in emphysema pathogenesis, we determined the association between the colony-forming or migratory capacity of circulating EPCs and the presence of emphysema in 51 patients with COPD. The patients were divided into emphysema (n = 23) and non-emphysema groups (n = 28) based on high-resolution computed tomography. Twenty-two smokers with normal lung function and 14 normal non-smokers served as controls. Circulating EPCs isolated from patients with emphysema showed significantly lower colony-forming units (CFUs) than those from patients with non-emphysema group, smokers with normal lung function, and normal non-smokers. EPCs from patients with emphysema showed significantly lower migratory capacity than those from normal non-smoking controls (p < 0.05). On multivariate analysis, the EPC-CFU was independently associated with emphysema (OR 0.944, 95% CI = 0.903-0.987, p = 0.011). Thus, impaired functions of circulating EPCs may contribute to the development of emphysema.

Download full-text PDF

Source
http://dx.doi.org/10.1620/tjem.227.321DOI Listing

Publication Analysis

Top Keywords

circulating epcs
16
patients emphysema
12
emphysema
11
capacity circulating
8
circulating endothelial
8
endothelial progenitor
8
progenitor cells
8
emphysema chronic
8
endothelial cell
8
emphysema pathogenesis
8

Similar Publications

Sickle cell disease (SCD) is a devastating hemolytic disease, marked by recurring bouts of painful vaso-occlusion, leading to tissue damage from ischemia/reperfusion pathophysiology. Central to this process are oxidative stress, endothelial cell activation, inflammation, and vascular dysfunction. The endothelium exhibits a pro-inflammatory, pro-coagulant, and enhanced permeability phenotype.

View Article and Find Full Text PDF

Endothelial progenitor cells as an angiogenic biomarker for the diagnosis and prognosis of lung cancer.

Rep Pract Oncol Radiother

December 2024

Radiobiology Laboratory, Department of Molecular Biology and Biotechnology, Atomic Energy Commission (AEC), Damascus, Syria.

Background: Angiogenesis is mediated by endothelial progenitor cells (EPCs) derived from bone-marrow. In this prospective study, we tried to investigate the clinical utility of circulating EPCs in lung cancer (LC) patients.

Materials And Methods: Flow cytometry technique was used to assess circulating EPCs according to the immuno-phenotype CD45 CD34 CD133 CD146 mononuclear cells.

View Article and Find Full Text PDF

Background: The role of circulating endothelial progenitor cells (cEPCs) in vascular repair and their association to cardiovascular protection is well established.

Objectives: We examined the effect of proprotein convertase subtilisin kexin type 9 monoclonal antibodies (PCSK9 mAb) on cEPCs in adults with hypercholesterolemia and cardiovascular disease, aiming to establish a pleotropic class effect.

Methods: Non-interventional prospective study in patients with cardiovascular disease treated with either evolocumab or alirocumab.

View Article and Find Full Text PDF
Article Synopsis
  • * This systematic review included 22 studies focusing on elderly patients with clinical diagnoses of strokes, assessing how EPC levels relate to clinical outcomes.
  • * Higher EPC levels were associated with better functional outcomes, reduced infarct growth, and lower recurrence risk in ischemic strokes, suggesting that EPC quantification could be valuable in evaluating stroke prognosis.
View Article and Find Full Text PDF
Article Synopsis
  • A phase II randomized controlled trial investigated the safety and potential benefits of intracarotid arterial administration (ICAA) of autologous CD34+ cells in patients recovering from acute ischemic stroke (IS) within 14 ± 7 days after the event.
  • Out of 28 patients, those in the cell-treated group showed significant improvement in angiogenesis and better overall recovery scores compared to a control group that received only standard medical therapy.
  • The treatment was found to be 100% safe without any long-term complications, suggesting that ICAA of CD34+ cells could be an effective option for enhancing recovery after IS.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!